BELLEVUE GROUP AG Relmada Therapeutics, Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$1.96M
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

+94.94%
quarter

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +51.96% 18.18K shares 1.30M $37.02 53.18K
Q2 2022 share Increase +118.75% 19K shares 233K $18.99 35K
Q1 2022 share Increase 0.00% 16K shares 432K $26.99 16K